Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

Genes and Development

Volumn 13, Issue 9, 1999, Pages 1055-1066

  Gale, Nicholas W ^a   Yancopoulos, George D ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; CAPILLARY; CELL SPECIFICITY; GROWTH REGULATION; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0033135876     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.9.1055     Document Type: Review

References (76)

1. Adams, R.H., G.A. Wilkinson, C. Weiss, F. Diella, N.W. Gale, U. Deutsch, W. Risau, and R. Klein. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes & Dev. 3: 295-306.
2. Brambilla, R., A. Schnapp, F. Casagranda, J.P. Labrador, A.D. Bergemann, J.G. Flanagan, E.B. Pasquale, and R. Klein. 1995. Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases. EMBO J. 14: 3116-3126.
3. Brown, D. 1993. The tyrosine kinase connection: How GPI-anchored proteins activate T-cells. Curr. Opin. Immunol. 5: 349-354.
4. Bruckner, K., E.B. Pasquale, and R. Klein. 1997. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 275: 1640-1643.
5. Buchert, M., S. Schneider, V. Meskenaite, M.T. Adams, E. Canaani, T. Baechi, K. Moelling, and C.M. Hovens. 1999. The Junction-associated protein AF-6 interacts and clusters with specific Eph receptor tyrosine kinases at specialized sites of cell-cell contact in the brain. J. Cell Biol. 144: 361-371.
6. Carmeliet, P. and D. Collen. 1999 Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol. 237: 133-158.
7. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy. 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
8. Chen, J., A. Nachabah, C. Scherer, P. Ganju, A. Reith, R. Bronson, and H.E. Ruley. 1996. Germ-line inactivation of the murine Eck receptor tyrosine kinase by gene trap retroviral insertion. Oncogene 12: 979-988.
9. Daniel, T.O., E. Stein, D.P. Cerretti, P.L. St. John, B. Robert, and D.R. Abrahamson. 1996. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int. Suppl. 57: S73-S81.
10. Davis, S., N.W. Gale, T.H. Aldrich, P.C. Maisonpierre, V. Lhotak, T. Pawson, M. Goldfarb, and G.D. Yancopoulos. 1994. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266: 816-819.
11. Davis, S., T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain, T.E. Ryan, J. Bruno, C. Radziejewski, P.C. Maisonpierre, and G.D. Yancopoulos. 1996. Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169.
12. Dumont, D.J., L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K. Pajusola, M. Breitman, and K. Alitalo. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949.
13. Durbin, L., C. Brennan, K. Shiomi, J. Cooke, A. Barrios, S. Shanmugalingam, B. Guthrie, R. Lindberg, and N. Holder. 1998. Eph signaling is required for segmentation and differentiation of the somites. Genes & Dev. 12: 3096-3109.
14. Dvorak, H.F., J.A. Nagy, D. Feng, L.F. Brown, and A.M. Dvorak. 1999. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237: 97-132.
15. Eph Nomenclature Committee. 1997. Unified nomenclature for Eph family receptors and their ligands, the Ephrins. Cell 90: 403-404.
16. Eriksson, U. and K. Alitalo. 1999. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr. Top. Microbiol. Immunol. 237: 41-57.
17. Ferrara, N. 1999. Vascular endothelial growth factor: Molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237: 1-30.
18. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K.S. O'Shea, L. Powell-Braxton, K.J. Hillan, and M.W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
19. Flanagan, J.G. and P. Vanderhaeghen. 1998. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21: 309-345.
20. Flenniken, A.M., N.W. Gale, G.D. Yancopoulos, and D.G. Wilkinson. 1996 Distinct and overlapping expression patterns of ligands for Eph-related receptor tyrosine kinases during mouse embryogenesis. Dev. Biol. 179: 382-401.
21. Folkman, J. and P.A. D'Amore. 1996. Blood vessel formation: What is its molecular basis? Cell 87: 1153-1155.
22. Fong, G.H., J. Rossant, M. Gertsenstein, and M.L. Breitman. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
23. Gale, N.W., A. Flenniken, D.C. Compton, N. Jenkins, N.G. Copeland, D.J. Gilbert, S. Davis, D.G. Wilkinson, and G.D. Yancopoulos. 1996a. Elk-L3, a novel transmembrane ligand for the Eph family of receptor tyrosine kinases, expressed in embryonic floor plate, roof plate and hindbrain segments. Oncogene 13: 1343-1352.
24. Gale, N.W., S.J. Holland, D.M. Valenzuela, A. Flenniken, L. Pan, T.E. Ryan, M. Henkemeyer, K. Strebhardt, H. Hirai, D.G. Wilkinson et al. 1996b. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17: 9-19.
25. Gale, N.W. and G.D. Yancopoulos. 1997. Ephrins and their receptors: A repulsive topic? Cell. Tissue Res. 290: 227-241.
26. Gassmann, M. and G. Lemke. 1997. Neuregulins and neuregulin receptors in neural development. Curr. Opin. Neurobiol. 7: 87-92.
27. George, S.E., K. Simokat, J. Hardin, and A.D. Chisholm. 1998. The VAB-1 Eph receptor tyrosine kinase functions in neural and epithelial morphogenesis in C. elegans. Cell 92: 633-643.
28. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science 277: 48-50.
29. Hanks, S.K. and A.M. Quinn. 1991. Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200: 38-62.
30. Henkemeyer, M., D. Orioli, J.T. Henderson, T.M. Saxton, J. Roder, T. Pawson, and R. Klein. 1996. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86: 35-46.
31. Himanen, J.P., M. Hentemeyer, and D.B. Nikolou. 1998. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2. Nature 396: 486-491.
32. Hiratsuka, S., O. Minowa, J. Kuno, T. Noda, and M. Shibuya. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. 95: 9349-9354.
33. Hock, B., B. Bohme, T. Karn, T. Yamamoto, K. Kaibuchi, U. Holtrich, S. Holland, T. Pawson, H. Rubsamen-Waigmann, and K. Strebhardt. 1998. PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. Proc. Natl. Acad. Sci. 95: 9779-9784.
34. Holland, S.J., N.W. Gale, G. Mbamalu, G.D. Yancopoulos, M. Henkemeyer, and T. Pawson. 1996. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383: 722-725.
35. Holzman, L.B., R.M. Marks, and V.M. Dixit. 1990. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol. Cell. Biol. 10: 5830-5838.
36. Hsueh, Y.P. and M. Sheng. 1998. Eph receptors, ephrins, and PDZs gather in neuronal synapses. Neuron 21: 1227-1229.
37. Huynh-Do, U., E. Stein, A.A. Lane, D.P. Cerretti, and T.O. Daniel. 1999. Defined durface densities of Ephrin-B1 determine EphB1-coupled activation of cell attachment through ανβ3 and α5β1 integrins. EMBO J..
38. Koblizek, T.I., C. Weiss, G.D. Yancopoulos, U. Deutsch, and W. Risau. 1998. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8: 529-532.
39. Kramer, R., N. Bucay, D.J. Kane, L.E. Martin, J.E. Tarpley, and L.E. Theill. 1996. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc. Natl. Acad. Sci. 93: 4833-4838.
40. Krull, C.E., R. Lansford, N.W. Gale, A. Collazo, C. Marcelle, G.D. Yancopoulos, S.E. Fraser, and M. Bronner-Fraser. 1997. Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr. Biol. 7: 571-580.
41. Kukk, E., A. Lymboussaki, S. Taira, A. Kaipainen, M. Jeltsch, V. Joukov, and K. Alitalo. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837.
42. Lee, K.F., H. Simon, H. Chen, B. Bates, M.C. Hung, and C. Hauser. 1995. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378: 394-398.
43. Lin, D., G.D. Gish, Z. Songyang, and T. Pawson. 1999. The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif. J. Biol. Chem. 274: 3726-3733.
44. Lindahl, P., B.R. Johansson, P. Leveen, and C. Betsholtz. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
45. Maisonpierre, P.C., C. Suri, P.F. Jones, S. Bartunkova, S.J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T.H. Aldrich, N. Papadopoulos, et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
46. McBride, J.L. and J.C. Ruiz. 1998. Ephrin-A1 is expressed at sites of vascular development in the mouse. Mech. Dev. 77: 201-204.
47. Meyer, D. and C. Birchmeier. 1995 Multiple essential functions of neuregulin in development. Nature 378: 386-390.
48. Neufeld, G., T. Cohen, S. Gengrinovitch, and Z. Poltorak. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13: 9-22.
49. O'Leary, D.D.M., P.A. Yates, and T. McLaughlin. 1999. Molecular development of sensory maps: Representing sights and smells in the brain. Cell 96: 255-269.
50. Orioli, D., M. Henkemeyer, G. Lemke, R. Klein, and T. Pawson. 1996. Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. EMBO J. 15: 6035-6049.
51. Pandey, A., H. Shao, R.M. Marks, P.J. Polverini, and V.M. Dixit. 1995. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha induced angiogenesis. Science 268: 567-569.
52. Park, S., J. Frisen, and M. Barbacid. 1997. Aberrant axonal projections in mice lacking EphA8 (Eek) tyrosine protein kinase receptors. EMBO J. 16: 3106-3114.
53. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
54. Robinson, V., A. Smith, A.M. Flenniken, and D.G. Wilkinson. 1997. Roles of Eph receptors and ephrins in neural crest pathfinding. Cell. Tissue Res. 290: 265-274.
55. Sakano, S., R. Serizawa, T. Inada, A. Iwama, A. Itoh, C. Kato, Y. Shimizu, F. Shinkai, R. Shimizu, S. Kondo, et al.. 1996. Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. Oncogene 13: 813-822.
56. Sato, T.N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74.
57. Schultz, J., C.P. Ponting, K. Hofmann, and P. Bork. 1997. SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 6: 249-253.
58. Shalaby, F., J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.F. Wu, M.L. Breitman, and A.C. Schuh. 1995. Failure of blood-island formation and vasculogenesis in FK-1-deficient mice. Nature 376: 62-66.
59. Shalaby F., J. Ho, W.L. Stanford, K.D. Fischer, A.C. Schuh, L. Schwartz, A. Bernstein, and J. Rossant. 1997. A requirement for FIKI in primitive and definitive hematopoiesis and vasculogenesis. Cell 89: 981-990.
60. Smith, A., Robinson, K. Patel, and D.G. Wilkinson. 1997. The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells. Curr. Biol. 1: 561-570.
61. Stapleton, D., I. Balan, T. Pawson, and F. Sicheri. 1999. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat. Struct. Biol. 6: 44-49.
62. Stein, E., U. Huynh-Do, A.A. Lane, D.P. Cerretti, and T.O. Daniel. 1998a. Nck recruitment to Eph receptor, EphB1/ ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 273: 1303-1308.
63. Stein, E., A.A. Lane, D.P. Cerretti, H.O. Schoecklmann, A.D. Schroff, R.L. Van Etten, and T.O. Daniel. 1998b. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes & Dev. 12: 667-678.
64. Suri, C., P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos. 1996. Requisite role of Angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
65. Suri, C., J. McClain, G. Thurston, D.M. McDonald, H. Zhou, E.H. Oldmixon, T.N. Sato, and G.D. Yancopoulos. 1998. Increased vascularization in mice overexpressing Angiopoietin-1. Science 282: 468-471.
66. Thanos, C.D., K.E. Goodwill, and J.U. Bowie. 1999. Oligomeric structure of the human EphB2 receptor SAM domain. Science 283: 833-836.
67. Thurston, G., P. Baluk, A. Hirata, and D.M. McDonald. 1996. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am. J. Physiol. 271: H2547-H2562.
68. Torres, R., B.L. Firestein, H. Dong, J. Staudinger, E.N. Olson, R.L. Huganir, D.S. Bredt, N.M. Gale, and G.D. Yancopoulos. 1998. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron 21: 1453-1463.
69. Valenzuela, D.M., J.A. Griffiths, J. Rojas, T.H. Aldrich, P.F. Jones, H. Zhou, J. McClain, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, et al. 1999. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. 96: 1904-1909.
70. Wang, H.U. and D.J. Anderson. 1997. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 18: 383-396.
71. Wang, H.U., Z.F. Chen, and D.J. Anderson. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753.
72. Winslow, J.W., P. Moran, J. Valverde, A. Shih, J.Q. Yuan, S.C. Wong, S.P. Tsai, A. Goddard, W.J. Henzel, F. Hefti et al. 1995. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron 14: 973-981.
73. Xu, Q., G. Alldus, N. Holder, and D.G. Wilkinson. 1995. Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain. Development 121: 4005-4016.
74. Xu, Q., G. Alldus, R. Macdonald, D.G. Wilkinson, and N. Holder. 1996. Function of the Eph-related kinase rtk1 in patterning of the zebrafish forebrain. Nature 381: 319-322.
75. Yancopoulos, G.D., M. Klagsburn, and J. Folkman. 1998. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border. Cell 93: 661-664.
76. Zhao, J.J. and G. Lemke. 1998. Selective disruption of neuregulin-1 function in vertebrate embryos using ribozyme-tRNA transgenes. Development 125: 1899-1907.-